Drug Approvals
Boehringer Ingelheim’s SPEVIGO® Receives Breakthrough Therapy Designation (BTD) from the United States Food and Drug Administration (FDA)
The United States Food and Drug Administration (FDA) and China’s National Medical Products Administration (NMPA) granted these designations based on
Monday, May 8, 2023
